{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:06:06Z","timestamp":1784027166109,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.psychres.2017.12.028","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T23:39:41Z","timestamp":1513121981000},"page":"243-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate"],"prefix":"10.1016","volume":"261","author":[{"given":"Fatemeh","family":"Behdani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyede Narjes","family":"Roudbaraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Saberi-Karimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Tayefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paria","family":"Hebrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Akhavanrezayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh Vahabi","family":"Amlashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Ferns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ghayour-Mobarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.psychres.2017.12.028_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain \u0277\u22123 fatty acids for indicated prevention of psychotic disorders. a randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.12.028_bib2","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1038\/tp.2013.110","article-title":"A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E\u00feC in schizophrenia","volume":"3","author":"Bentsen","year":"2013","journal-title":"Transl. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2017.12.028_bib3","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4088\/JCP.v68n1206","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial","volume":"68","author":"Berger","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2017.12.028_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1592\/phco.27.5.633","article-title":"Effect of omega-3 fatty acid supplementation on the arachidonic acid: eicosapentaenoic acid ratio","volume":"27","author":"Burns","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.psychres.2017.12.028_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/j.1440-1614.2006.01869.x","article-title":"Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine","volume":"40","author":"Caniato","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.12.028_bib6","doi-asserted-by":"crossref","first-page":"e0139565","DOI":"10.1371\/journal.pone.0139565","article-title":"Effects of omega-3 fatty acid supplementation on glucose control and lipid levels in Type 2 diabetes: a meta-analysis","volume":"10","author":"Chen","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.psychres.2017.12.028_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/2277-9175.124644","article-title":"The effect of conjugated linoleic acids and omega-3 fatty acids supplementation on lipid profile in atherosclerosis","volume":"3","author":"Eftekhari","year":"2014","journal-title":"Adv. Biomed. Res."},{"issue":"9","key":"10.1016\/j.psychres.2017.12.028_bib8","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.159.9.1596","article-title":"Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia","volume":"159","author":"Emsley","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2017.12.028_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2006.03.023","article-title":"The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial","volume":"84","author":"Emsley","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.12.028_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fgene.2013.00208","article-title":"Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hippocampus","volume":"4","author":"English","year":"2013","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.psychres.2017.12.028_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2008-2231-20-43","article-title":"Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial","volume":"20","author":"Faghihi","year":"2012","journal-title":"DARU"},{"issue":"12","key":"10.1016\/j.psychres.2017.12.028_bib12","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1176\/appi.ajp.158.12.2071","article-title":"A placebocontrolled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia","volume":"158","author":"Fenton","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.12.028_bib13","series-title":"The Design and Analysis of Clinical Experiments","author":"Fleiss","year":"1986"},{"key":"10.1016\/j.psychres.2017.12.028_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1520-037X.2003.1332.x","article-title":"Beyond the Mediterranean diet: the role of omega-3 fatty acids in the prevention of coronary heart disease","volume":"6","author":"Harper","year":"2003","journal-title":"Prev. Cardiol."},{"key":"10.1016\/j.psychres.2017.12.028_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","article-title":"Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis","volume":"62","author":"Henderson","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2017.12.028_bib16","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.psychres.2017.12.028_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpsychires.2015.11.013","article-title":"A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia","volume":"73","author":"Pawelczyk","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2017.12.028_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12888-015-0473-2","article-title":"Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods","volume":"15","author":"Pawelczyk","year":"2015","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2017.12.028_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","article-title":"A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms","volume":"36","author":"Peet","year":"2002","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2017.12.028_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S0920-9964(00)00083-9","article-title":"Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia","volume":"49","author":"Peet","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2017.12.028_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.plefa.2003.08.018","article-title":"Omega-3 and omega-6 fatty acid concentrations in red blood cell membranes relate to schizotypal traits in healthy adults, Prostaglandins. Leukot","volume":"69","author":"Richardson","year":"2003","journal-title":"Essent. Fat. Acids"},{"issue":"1","key":"10.1016\/j.psychres.2017.12.028_bib22","first-page":"18","article-title":"Effect of early intervention with omega-3 on insulin resistance in patients initiated on olanzapine with either sodium valproate or lithium: a randomized, double-blind, placebo-controlled trial","volume":"5","author":"Toktam","year":"2010","journal-title":"Iran J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.12.028_bib23","first-page":"37","article-title":"Effect of omega-3 fatty acids on the serum lipid profile and microcirculation in patients with metabolic syndrome and hypertensive disease","volume":"87","author":"Vasil'ev","year":"2009","journal-title":"Klin. Med."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116313142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116313142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T09:45:40Z","timestamp":1621071940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178116313142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":23,"alternative-id":["S0165178116313142"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2017.12.028","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2017.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}